New pill targets advanced cancers in first human trial
NCT ID NCT06305247
Summary
This study is testing a new oral drug called IPN01194 in adults with advanced solid tumors that have spread and have specific genetic changes. The main goals are to find a safe and tolerable dose and to see if the drug can help shrink tumors. The study is open to people with certain advanced cancers, including melanoma, colorectal, pancreatic, and head and neck cancers, for whom standard treatments are no longer suitable.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Barcelona - Val D'Hebron
RECRUITINGBarcelona, Spain
-
Centre Léon Bérard - Lyon
RECRUITINGLyon, France
-
Fundacion Jimenez Diaz - Madrid
RECRUITINGMadrid, Spain
-
IGR-Villejuif
RECRUITINGVillejuif, France
-
Institut de Cancerologie de l'Ouest (St-Herblain)
RECRUITINGSaint-Herblain, France
-
M.D. Anderson Cancer Center Madrid
RECRUITINGMadrid, Spain
-
Paris Saint-Louis
RECRUITINGParis, France
-
Sarah Cannon Research Institute (SCRI) - Nashville
RECRUITINGNashville, Tennessee, 37203, United States
-
The Angeles Clinic and Research Institute - California
RECRUITINGLos Angeles, California, 90025, United States
-
UC San Diego Health System - La Jolla
WITHDRAWNSan Diego, California, 92037, United States
-
Virginia Cancer Specialist
RECRUITINGFairfax, Virginia, 22031, United States
-
Yale Cancer Center - New Heaven
RECRUITINGNew Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.